MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$1,254,078
EPS
-$0.28
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenues
-
86,727
129,390
211,140.5*
Research and development
720,973
791,581
993,475
1,050,810.5*
General and administrative
553,299
651,721
463,736
623,466*
Total costs and expenses
1,274,272
1,443,302
1,457,211
1,674,276.5*
Loss from operations
-1,274,272
-1,356,575
-1,327,821
-1,463,136*
Interest income, net
20,194
29,089
21,298
21,046.5
Total other income/(expense)
20,194
29,089
21,298
21,046.5*
Loss before income taxes
-1,254,078
-1,327,486
-1,306,523
-1,442,089.5
Provision for income taxes
-
0
-
-
Net loss
-1,254,078
-1,327,486
-1,306,523
-1,442,089.5
Basic EPS
-0.28
-0.31
-0.64
-1.376
Diluted EPS
-0.28
-0.31
-0.64
-1.376
Basic Average Shares
4,549,120
4,305,243
2,056,804
1,048,185*
Diluted Average Shares
4,549,120
4,305,243
2,056,804
1,048,185*
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
LIPO Income Statement Sankey Diagram
Sankey diagram visualizing LIPO income statement for the period
Net loss
-$1,254,078
(13.19%↑ Y/Y)
Interest income, net
$20,194
(36.65%↑ Y/Y)
Loss before income
taxes
-$1,254,078
(13.19%↑ Y/Y)
Total other
income/(expense)
$20,194
(36.65%↑ Y/Y)
Loss from operations
-$1,274,272
(12.69%↑ Y/Y)
Total costs and
expenses
$1,274,272
(-17.24%↓ Y/Y)
Research and development
$720,973
(-31.12%↓ Y/Y)
General and
administrative
$553,299
(12.21%↑ Y/Y)
Buy us a coffee
LIPELLA PHARMACEUTICALS INC. (LIPO)
LIPELLA PHARMACEUTICALS INC. (LIPO)